Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
$15.25
$15.23
$4.81
$15.37
$753.61M-0.06974,748 shs600 shs
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
$0.07
$0.06
$1.17
$37K1.1315.69 million shs96,558 shs
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
$46.18
-0.6%
$43.78
$31.02
$49.65
$4.00B1.33509,401 shs555,993 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
-0.62%+8.07%+6.23%-2.08%+29.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
4.6578 of 5 stars
2.34.02.53.43.72.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/A
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
N/AN/AN/AN/A
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
2.57
Moderate Buy$50.719.82% Upside

Current Analyst Ratings

Latest KIBO, ALNA, AERI, and HWC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$50.00 ➝ $46.00
4/17/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$55.00 ➝ $52.00
4/17/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$50.00
4/17/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$55.00 ➝ $57.00
4/17/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$48.00 ➝ $50.00
4/8/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$51.00 ➝ $45.00
4/1/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$48.00 ➝ $50.00
2/13/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$55.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
$194.13M3.88N/AN/A($3.32) per share-4.59
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
N/AN/AN/AN/A$0.23 per shareN/A
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
$1.91B2.10$5.94 per share7.77$44.49 per share1.04

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
-$74.81M-$0.77N/AN/AN/A-17.09%N/A-2.00%N/A
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
-$48.66MN/A0.00N/AN/AN/A-287.46%-146.58%N/A
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
$392.60M$4.2910.769.24N/A19.07%11.89%1.22%7/16/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/AN/A
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
N/AN/AN/AN/AN/A
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
$1.202.60%+3.57%27.97%1 Years

Latest KIBO, ALNA, AERI, and HWC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2024
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
Quarterly$0.302.54%3/4/20243/5/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/A
2.27
1.92
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
N/A
1.58
1.58
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
0.06
0.79
0.79

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
95.94%
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
7.33%
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
81.22%

Insider Ownership

CompanyInsider Ownership
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
4.44%
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
3.70%
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
1.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
37649.42 million47.22 millionOptionable
Allena Pharmaceuticals, Inc. stock logo
ALNA
Allena Pharmaceuticals
35122.08 million117.57 millionNot Optionable
Hancock Whitney Co. stock logo
HWC
Hancock Whitney
3,59186.61 million85.66 millionOptionable

KIBO, ALNA, AERI, and HWC Headlines

SourceHeadline
Hancock Whitney Raises Dividend 33%Hancock Whitney Raises Dividend 33%
marketwatch.com - April 26 at 2:04 AM
Hancock Whitney raises dividend by 33% to $0.40Hancock Whitney raises dividend by 33% to $0.40
msn.com - April 25 at 7:23 PM
Hancock Whitney Increases Quarterly Dividend 33%Hancock Whitney Increases Quarterly Dividend 33%
finance.yahoo.com - April 25 at 4:04 PM
Hancock Whitney Increases Quarterly Dividend 33%Hancock Whitney Increases Quarterly Dividend 33%
businesswire.com - April 25 at 4:00 PM
Louisiana State Employees Retirement System Takes Position in Hancock Whitney Co. (NASDAQ:HWC)Louisiana State Employees Retirement System Takes Position in Hancock Whitney Co. (NASDAQ:HWC)
marketbeat.com - April 23 at 4:51 AM
Foundry Partners LLC Trims Stock Position in Hancock Whitney Co. (NASDAQ:HWC)Foundry Partners LLC Trims Stock Position in Hancock Whitney Co. (NASDAQ:HWC)
marketbeat.com - April 21 at 10:26 PM
Hancock Whitney Co. (NASDAQ:HWC) Stock Position Raised by Knights of Columbus Asset Advisors LLCHancock Whitney Co. (NASDAQ:HWC) Stock Position Raised by Knights of Columbus Asset Advisors LLC
marketbeat.com - April 19 at 1:51 PM
We Think The Compensation For Hancock Whitney Corporations (NASDAQ:HWC) CEO Looks About RightWe Think The Compensation For Hancock Whitney Corporation's (NASDAQ:HWC) CEO Looks About Right
finance.yahoo.com - April 19 at 10:45 AM
Hancock Whitney Corp (HWC) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and ...Hancock Whitney Corp (HWC) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and ...
finance.yahoo.com - April 19 at 8:37 AM
DA Davidson Increases Hancock Whitney (NASDAQ:HWC) Price Target to $57.00DA Davidson Increases Hancock Whitney (NASDAQ:HWC) Price Target to $57.00
americanbankingnews.com - April 19 at 6:24 AM
Hancock Whitney (NASDAQ:HWC) Rating Reiterated by StephensHancock Whitney (NASDAQ:HWC) Rating Reiterated by Stephens
americanbankingnews.com - April 19 at 6:24 AM
Hancock Whitney (NASDAQ:HWC) Shares Gap Up  on Analyst UpgradeHancock Whitney (NASDAQ:HWC) Shares Gap Up on Analyst Upgrade
americanbankingnews.com - April 19 at 5:36 AM
DA Davidson Equities Analysts Boost Earnings Estimates for Hancock Whitney Co. (NASDAQ:HWC)DA Davidson Equities Analysts Boost Earnings Estimates for Hancock Whitney Co. (NASDAQ:HWC)
americanbankingnews.com - April 19 at 2:46 AM
Hancock Whitney (NASDAQ:HWC) Lifted to "Buy" at CitigroupHancock Whitney (NASDAQ:HWC) Lifted to "Buy" at Citigroup
americanbankingnews.com - April 19 at 1:44 AM
Hancock Whitney holds stock price target on stable outlookHancock Whitney holds stock price target on stable outlook
investing.com - April 19 at 1:14 AM
Hancock Whitneys (HWC) Overweight Rating Reaffirmed at Piper SandlerHancock Whitney's (HWC) Overweight Rating Reaffirmed at Piper Sandler
americanbankingnews.com - April 18 at 7:06 AM
Research Analysts Offer Predictions for Hancock Whitney Co.s FY2024 Earnings (NASDAQ:HWC)Research Analysts Offer Predictions for Hancock Whitney Co.'s FY2024 Earnings (NASDAQ:HWC)
marketbeat.com - April 18 at 6:16 AM
Hancock Whitney (NASDAQ:HWC) Price Target Cut to $46.00 by Analysts at Truist FinancialHancock Whitney (NASDAQ:HWC) Price Target Cut to $46.00 by Analysts at Truist Financial
americanbankingnews.com - April 18 at 5:52 AM
Hancock Whitney Corporation (HWC) Q1 2024 Earnings Call TranscriptHancock Whitney Corporation (HWC) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 18 at 5:11 AM
Piper Sandler Reiterates Overweight Rating for Hancock Whitney (NASDAQ:HWC)Piper Sandler Reiterates Overweight Rating for Hancock Whitney (NASDAQ:HWC)
marketbeat.com - April 17 at 4:27 PM
Hancock Whitney (NASDAQ:HWC) PT Lowered to $46.00Hancock Whitney (NASDAQ:HWC) PT Lowered to $46.00
marketbeat.com - April 17 at 4:27 PM
Hancock Whitney (NASDAQ:HWC) Raised to "Buy" at CitigroupHancock Whitney (NASDAQ:HWC) Raised to "Buy" at Citigroup
marketbeat.com - April 17 at 3:50 PM
Hancock Whitney (HWC) Q1 Earnings Beat on Fee Income GrowthHancock Whitney (HWC) Q1 Earnings Beat on Fee Income Growth
zacks.com - April 17 at 1:06 PM
A Glimpse Into The Expert Outlook On Hancock Whitney Through 6 AnalystsA Glimpse Into The Expert Outlook On Hancock Whitney Through 6 Analysts
benzinga.com - April 17 at 12:35 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aerie Pharmaceuticals logo

Aerie Pharmaceuticals

NASDAQ:AERI
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Allena Pharmaceuticals logo

Allena Pharmaceuticals

NASDAQ:ALNA
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Hancock Whitney logo

Hancock Whitney

NASDAQ:HWC
Hancock Whitney Corporation operates as the financial holding company for Hancock Whitney Bank that provides traditional and online banking services to commercial, small business, and retail customers. It offers various transaction and savings deposit products consisting of brokered deposits, time deposits, and money market accounts; treasury management services, secured and unsecured loan products including revolving credit facilities, and letters of credit and similar financial guarantees; and trust and investment management services to retirement plans, corporations, and individuals, and investment advisory and brokerage products. The company also provides commercial and industrial loans including real and non-real estate loans; construction and land development loans; and residential mortgages, as well as consumer loans. In addition, it offers commercial finance products to middle market and corporate clients, including leases and related structures; facilitates investments in new market tax credit activities and holding certain foreclosed assets; provides customers access to fixed annuity and life insurance products; and underwriting transactions products, as well as debt and mortgage-related securities. The company was founded in 1899 and is headquartered in Gulfport, Mississippi.